Other helminthiases

AB1_HELMINTHIASES_NOS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — B83 Hospital discharge: ICD-9 — 128 Hospital discharge: ICD-8 — 1289 Cause of death: ICD-10 — B83 Cause of death: ICD-9 — 128 Cause of death: ICD-8 — 1289 2 out of 7 registries used, show all original rules.	51
4. Check minimum number of events None	51
5. Include endpoints None	51
6. Filter based on genotype QC (FinnGen only)	49

Control definitions (FinnGen only)

Control exclude: AB1_HELMINTIASES

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF5

NAME	AB1_HELMINTHIASES_NOS
CONTROL_EXCLUDE	AB1_HELMINTIASES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	B83
HD_ICD_9	128
HD_ICD_8	1289
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	B83
COD_ICD_9	128
COD_ICD_8	1289
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other helminthiases based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	419	211	208
Only index persons	309	162	147
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	-	41.18	38.38
Only index persons	34.17	35.74	32.44

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	49	31	18
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	50.84	47.80	56.06

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
51: Matched controls
510

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

B83.9

ICD-10 Finland

Helminthiasis, unspecified

+∞

18.9

12899

ICD-8 Finland

Other and unspecified helminthiasis, Unspecified

+∞

9.7

B83.8

ICD-10 Finland

Other specified helminthiases

+∞

8.6

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3003327) Ova and parasites identified in Stool by Light microscopy

14.60

9.03

4.0

1.9

—

(3048689) Calprotectin [Mass/mass] in Stool

3.82

4.41

2.5

1.8

66.74

194.24

ug/g

0.84

(3007566) Smooth muscle Ab [Titer] in Serum

9.23

4.23

1.4

1.3

—

(3034770) Mitochondria Ab [Titer] in Serum

9.90

3.90

1.4

—

(3017181) Myelocytes/Leukocytes in Blood

3.70

3.03

4.2

6.1

0.20

0.50

—

(3001604) Monocytes [#/volume] in Blood

231

2.90

3.02

13.7

7.4

0.49

0.57

e9/l

1.72

205

(3006315) Basophils [#/volume] in Blood

232

2.88

2.97

13.8

7.4

0.04

e9/l

0.67

205

(3022145) Colonoscopy Study observation

3.07

2.82

1.3

1.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

108

2.61

2.66

1.8

1.3

0.48

0.88

u/ml

—

(3007164) IgA [Mass/volume] in Serum or Plasma

101

2.61

2.62

2.6

1.4

2.08

2.50

g/l

0.61

(3021589) Normoblasts [#/volume] in Blood

198

2.44

2.42

17.1

11.5

0.00

e9/l

-0.00

165

(42870588) Differential panel, method unspecified - Blood

153

2.24

2.06

11.4

6.6

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

3.21

1.79

1.0

1.1

—

(40768797) Stomach Pathology biopsy report

2.43

1.78

1.4

1.3

—

(3018418) pH of Serum or Plasma

136

2.09

1.70

5.0

7.39

7.40

0.18

104

(3024928) Oxygen saturation in Venous blood

3.84

1.65

1.0

3.4

60.30

62.16

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

3.84

1.65

1.0

1.2

—

(40768443) Skin Pathology biopsy report

2.95

1.48

1.2

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

3.34

1.47

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

3.34

1.47

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

3.34

1.47

1.2

—

(36660697) Celiac disease serology panel - Serum

2.32

1.39

1.0

1.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

2.00

1.34

10.0

6.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2.80

1.24

1.6

1.7

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2.12

1.15

1.6

2.5

1.76

1.31

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.12

1.15

1.1

1.3

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

2.02

1.08

3.8

8.1

104.36

104.59

mmol/l

0.07

(3004716) Salmonella sp identified in Stool by Organism specific culture

2.29

0.95

1.2

—

(3000492) Spirometry study

2.02

0.93

2.3

1.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.94

0.91

1.8

2.2

—

(3013512) EKG study

158

0.54

0.90

5.5

3.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1.79

0.89

2.5

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.90

0.87

1.3

1.6

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

269

1.64

0.86

4.2

5.2

6.35

6.62

mmol/l

0.44

256

(1761868) Lipid panel - Serum or Plasma

164

1.60

0.82

3.9

3.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.81

0.0

3.3

—

10.29

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.80

0.0

3.0

—

3.66

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.80

0.0

3.0

—

4.18

—

(40768804) Tissue Pathology biopsy report

185

1.56

0.77

2.6

2.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.70

0.73

1.8

1.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

2.02

0.73

1.2

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.76

0.71

2.2

2.3

—

(3018095) Leukocytes [#/volume] in Urine

178

1.53

0.71

4.7

4.9

160.02

44.09

e6/l

0.39

124

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1.94

0.70

1.8

4.9

23.72

24.57

mmol/l

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.67

0.64

2.9

1.8

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

108

1.55

0.62

2.5

2.4

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

333

1.55

0.62

16.7

8.5

79.32

76.59

u/l

0.19

318

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1.61

0.61

3.3

3.4

0.69

0.77

e6/l

—

(3021601) Nitrite [Presence] in Urine by Test strip

242

1.46

0.59

5.5

4.3

0.00

estimate

—

(3024354) Oxygen [Partial pressure] in Venous blood

1.75

0.59

1.8

2.8

4.67

4.59

kpa

—

(3000991) Gas panel - Venous blood

1.70

0.58

1.0

10.9

—

(3030467) Casts [#/volume] in Urine by Automated count

138

1.47

0.56

4.1

3.5

0.01

0.31

e6/l

1.68

(46235355) HIV 1 and 2 tests - Meaningful Use set

103

1.50

0.52

2.0

1.9

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.53

0.49

1.4

1.9

—

(3029937) Albumin [Presence] in Urine by Test strip

133

1.42

0.47

5.5

4.0

0.00

estimate

—

(36304419) Bacteria [Presence] in Urine

134

1.40

0.45

4.3

3.3

—

estimate

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1.68

0.44

1.0

10.5

0.96

1.08

mmol/l

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1.62

0.43

1.4

6.3

7.12

9.67

mmol/l

—

(3017732) Neutrophils [#/volume] in Blood

1.42

0.43

3.9

4.1

4.15

4.40

e9/l

—

(3025941) Bacteria identified in Stool by Culture

1.57

0.42

1.4

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

154

1.37

0.42

2.6

2.4

—

(40758558) Short blood count panel - Blood

145

1.37

0.41

15.7

7.2

—

(40761511) CBC panel - Blood by Automated count

442

0.72

0.40

16.6

13.0

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

165

1.35

0.40

4.6

3.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.52

0.38

1.2

1.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.52

0.38

5.0

3.4

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

466

0.71

0.36

39.9

24.4

91.20

91.26

0.03

460

(3007461) Platelets [#/volume] in Blood

466

0.71

0.36

40.1

24.5

242.09

254.15

e9/l

0.53

457

(3000963) Hemoglobin [Mass/volume] in Blood

466

0.71

0.36

40.3

24.6

133.42

134.17

g/l

0.15

460

(3010813) Leukocytes [#/volume] in Blood

466

0.71

0.36

40.2

24.4

5.99

6.73

e9/l

1.96

454

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

466

0.71

0.36

40.0

25.0

39.36

40.10

0.32

460

(3026361) Erythrocytes [#/volume] in Blood

466

0.71

0.36

40.1

24.4

4.39

4.44

e12/l

0.30

455

(3035941) MCH [Entitic mass]

466

0.71

0.36

40.0

24.3

30.34

0.01

460

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1.34

0.34

1.8

3.8

5.58

5.77

kpa

—

(3045414) Leukocytes [Presence] in Urine

1.34

0.34

2.2

2.0

—

0.00

estimate

—

(3015736) pH of Urine

198

1.29

0.33

5.3

3.9

6.27

6.23

0.06

109

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

201

1.26

0.28

2.2

106.92

97.24

pmol/l

0.37

100

(3031040) Bacteria [#/volume] in Urine by Automated count

301

1.27

0.28

6.6

5.3

—

104.63

—

(3042936) Bacteria identified in Isolate by Culture

1.26

0.27

2.2

1.7

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1.33

0.24

3.5

3.4

3.40

1.73

e6/l

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

0.21

0.0

1.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.4

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

0.00

0.21

0.0

1.4

—

(3002032) Base excess in Venous blood by calculation

1.31

0.21

1.5

3.7

0.65

2.40

mmol/l

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.6

—

(3037756) Immunofixation for Serum or Plasma

0.00

0.21

0.0

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.3

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

0.20

0.0

1.1

—

(3019150) Specific gravity of Urine by Refractometry

101

1.25

0.18

4.7

4.1

1.02

kg/l

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

209

1.18

0.17

6.4

6.2

1.22

mmol/l

0.13

191

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.15

0.17

1.5

1.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

0.74

0.17

1.8

2.0

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

431

0.86

0.16

27.1

16.2

20.37

23.29

mg/l

0.27

363

(3026008) Bacteria identified in Urine by Culture

156

1.13

0.09

2.8

3.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

456

0.89

0.09

20.4

12.1

26.40

24.27

u/l

0.36

444

(3020564) Creatinine [Moles/volume] in Serum or Plasma

455

0.91

0.09

30.6

20.4

72.53

75.64

umol/l

0.54

448

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

247

1.11

0.08

7.2

6.5

12.69

10.65

umol/l

0.44

236

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

410

1.14

0.07

24.2

16.5

86.55

81.53

ml/min/173m2

0.87

380

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

290

1.08

0.04

3.4

3.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

137

0.93

0.02

6.5

3.7

0.20

0.00

estimate

—

(3023368) Bacteria identified in Blood by Culture

134

1.06

0.01

4.5

4.3

—

(3003694) ABO and Rh group [Type] in Blood

134

1.06

0.01

1.8

1.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

214

1.05

0.00

3.5

2.7

—

estimate

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

105

0.94

0.00

4.0

5.0

1.95

2.27

ug/l

—

(3002256) Pathology report gross observation

0.92

0.00

1.6

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

0.00

-0.00

0.0

1.3

—

14.00

—

(44806071) Cardiolipin IgM antibody measurement

0.00

-0.00

0.0

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

436

1.07

-0.00

26.5

18.4

3.83

3.94

mmol/l

2.36

428

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

-0.00

0.0

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

0.00

-0.00

0.0

1.7

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

3.88

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

-0.00

0.0

1.2

—

32.40

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

-0.00

0.0

1.4

—

1.20

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

6.8

—

203.40

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

0.90

-0.00

2.0

1.9

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

0.00

-0.00

0.0

1.2

—

103.40

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3023419) Bacteria identified in Sputum by Culture

0.00

-0.00

0.0

2.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.04

-0.00

3.0

1.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

-0.00

0.0

3.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

0.00

-0.00

0.0

1.7

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

-0.00

0.0

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

-0.00

0.0

1.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

-0.00

0.0

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

0.00

-0.00

0.0

2.0

—

(4281824) Cell count and differential, peritoneal fluid

0.00

-0.00

0.0

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

-0.00

0.0

1.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

0.00

-0.00

0.0

1.0

—

7.20

—

(3045142) Bone marrow Pathology biopsy report

0.00

-0.00

0.0

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

110.33

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

436

1.07

-0.00

26.1

18.1

140.02

139.76

mmol/l

0.36

428

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

-0.00

0.0

2.0

—

1098.00

—

(3022806) Fractional oxyhemoglobin in Capillary blood

0.00

-0.00

0.0

3.8

—

87.62

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

12.48

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

-0.00

0.0

1.1

—

(4035726) Immunohistochemistry procedure

1.00

-0.00

1.6

1.3

—

(3005570) Glucose [Moles/volume] in Urine

0.00

-0.00

0.0

2.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

2.6

—

0.67

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

-0.00

0.0

1.0

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

-0.00

0.0

1.4

—

109.22

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

-0.00

0.0

1.4

—

3.94

—

(37208534) Antinuclear antibody arbitrary concentration in serum

0.00

-0.00

0.0

1.0

—

(21491868) Cryoglobulin [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

-0.00

0.0

1.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

-0.00

0.0

1.0

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

-0.00

0.0

1.8

—

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_HELMINTHIASES_NOS and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have AB1_HELMINTHIASES_NOS.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: AB1_HELMINTHIASES_NOS – Other helminthiases

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other helminthiases

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints